Martha Wang

Managing Associate


Fan (Martha) Wang, a Managing Associate in Orrick’s Beijing office, is a member of the M&A and Private Equity Group.

Martha regularly represents Chinese and international clients in cross-border M&A, private equity investments and financings, joint ventures, foreign direct investments and other compliance matters.

She has represented clients from a broad range of industries, including TMT, financial services, healthcare, consumer products, energy, manufacturing, etc.

In addition, she has experience in handling initial public offerings, debt and equity securities offerings, pre-IPO investments, as well as advising on restructuring, employment, antitrust, and general corporate matters.
    • Toyota Motor in its US$400 million Series C investment into, a leading autonomous driving AI company in China.
    • A leading multinational automobile manufacturer in its Series A investment in a Chinese automobile navigation services provider.
    • China Reform Conson Soochow Overseas Fund I L.P. in its investment in the US$150 million Series D financing by Akeso Biopharma, Inc., a leading innovative biotech company in China focusing on discovering and developing biological medicine, diagnostic reagent and antibody drugs.
    • Geo-Jade Petroleum Corporation, the largest private oil exploration and production company in China, in its joint venture and strategic cooperation relating to the exploration, construction, production and refinement of natural gas facilities and pipelines in Kazakhstan.
    • A state-owned sovereign fund in its indirect investment in a mining project in Argentina.
    • A Chinese listed company in its investment in a German hotel management company.
    • Hotelbeds in the restructuring of its PRC subsidiaries and acquisition of a Chinese provider of travel services.    
    • Vista Group International in the sale of equity in its PRC subsidiary to Weying, a leading online ticket sales platform invested by Tencent.
    • Aspen Pharmacare in its cooperation with a leading pharmaceutical group in China.
    • Thaicom in its acquisition of a satellite hub system on gateway stations in China.
    • Blancco Technology Group in its establishment of a joint venture in China.
    • Clean Energy Finance Corporation in its acquisition of a solar energy company and the relevant IP assignment and licences.
    • Capital Healthcare Group in its various pre-IPO investments.
    • Shanghai TYD Technology Holdings in setting up an internet and artificial intelligence joint venture.
    • Macquarie Asia Infrastructure Investments in its acquisition of a Foshan environmental protection and technology company.
    • Great Wall Pan Asia International Investment in its investment in a Beijing real estate company.
    • LR Capital in its acquisition of an international payment and exchange company.
    • Harbin Bank in setting up consumer finance companies and rural banks.
    • Standard Chartered Bank (Hong Kong) Limited in the SDR100 million (approximately US$139 million) panda bonds offering.